All In Biotech

Drug Trial Radar · NCT06724237

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

A Randomized Phase III Study to Evaluate Benefits of Autologous Stem Cell Transplant in Patients With Peripheral T Cell Lymphoma That Achieved a First Complete Remission (CR1) Following Induction Therapy (PTCL-STAT)

Last checked: Nov 20, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 294 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

294

Planned (sponsor's estimate)

Start

Jun 18, 2025

Primary completion

Apr 30, 2074

Study completion Apr 30, 2075

Sponsor

Lead sponsor
Eastern Cooperative Oncology GroupResearch network
Sponsor type
Research network
Collaborators
National Cancer Institute (NCI)
First posted
Dec 9, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This phase III trial compares the effect of high dose chemotherapy and the patients' own (autologous) stem cells to observation only in patients with peripheral T-cell lymphoma who achieved a complete response after initial chemotherapy. Usual treatment after a complete response may include observation or high dose chemotherapy followed by an autologous stem cell transplant, however, it is not known if a transplant if beneficial. Giving chemotherapy before a stem cell transplant helps kill cancer cells in the body and helps make room in the patient's bone marrow for new blood-forming cells (stem cells) to grow. Stem cells removed prior to treatment are then returned to the patient to replace the blood forming cells that were destroyed by the chemotherapy. Giving high dose chemotherapy followed by an autologous stem cell transplant may be more effective compared to observation only in treating patients with peripheral T-cell lymphoma who have achieved a complete response after initial chemotherapy.

Conditions

  • Anaplastic Large Cell Lymphoma, ALK-Negative
  • Follicular Helper T-Cell Lymphoma
  • Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type
  • Peripheral T-Cell Lymphoma, Not Otherwise Specified

Interventions

  • Autologous Hematopoietic Stem Cell TransplantationProcedure

    Undergo ASCT

  • Best PracticeOther

    Receive standard of care observation

  • Biospecimen CollectionProcedure

    Undergo blood sample collection

  • Bone Marrow AspirationProcedure

    Undergo bone marrow aspiration and biopsy

  • Bone Marrow BiopsyProcedure

    Undergo bone marrow aspiration and biopsy

  • Computed TomographyProcedure

    Undergo CT or PET/CT

  • High Dose ChemotherapyDrug

    Receive high dose chemotherapy

  • LeukapheresisProcedure

    Undergo leukapheresis

  • Positron Emission TomographyProcedure

    Undergo PET/CT

  • Stem Cell Mobilization TherapyDrug

    Receive stem cell mobilization therapy

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression-free survival (PFS)Time frame: From study randomization to documented disease progression or death, whichever occurs first, assessed up to 12 years

Locations

165 sites in 2 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham Cancer Center

    Birmingham, Alabama · Not yet recruiting

  • Anchorage Associates in Radiation Medicine

    Anchorage, Alaska · Recruiting

  • Alaska Breast Care and Surgery LLC

    Anchorage, Alaska · Recruiting

  • Alaska Oncology and Hematology LLC

    Anchorage, Alaska · Recruiting

  • Alaska Women's Cancer Care

    Anchorage, Alaska · Recruiting

  • Katmai Oncology Group

    Anchorage, Alaska · Recruiting

  • Providence Alaska Medical Center

    Anchorage, Alaska · Recruiting

  • Fairbanks Memorial Hospital

    Fairbanks, Alaska · Active not recruiting

  • Mayo Clinic Hospital in Arizona

    Phoenix, Arizona · Recruiting

  • Banner University Medical Center - Tucson

    Tucson, Arizona · Recruiting

  • University of Arizona Cancer Center-North Campus

    Tucson, Arizona · Recruiting

  • Providence Saint Joseph Medical Center/Disney Family Cancer Center

    Burbank, California · Recruiting

  • City of Hope Comprehensive Cancer Center

    Duarte, California · Recruiting

  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care

    Irvine, California · Recruiting

  • Contra Costa Regional Medical Center

    Martinez, California · Active not recruiting

  • Providence Queen of The Valley

    Napa, California · Recruiting

  • UC Irvine Health/Chao Family Comprehensive Cancer Center

    Orange, California · Recruiting

  • Providence Medical Foundation - Santa Rosa

    Santa Rosa, California · Recruiting

  • Providence Santa Rosa Memorial Hospital

    Santa Rosa, California · Recruiting

  • BASS Medical Group - Lennon

    Walnut Creek, California · Active not recruiting

  • Rocky Mountain Cancer Centers-Aurora

    Aurora, Colorado · Active not recruiting

  • Boulder Community Foothills Hospital

    Boulder, Colorado · Active not recruiting

  • Rocky Mountain Cancer Centers-Boulder

    Boulder, Colorado · Active not recruiting

  • Rocky Mountain Cancer Centers - Centennial

    Centennial, Colorado · Active not recruiting

  • The Women's Imaging Center

    Denver, Colorado · Active not recruiting

  • Colorado Blood Cancer Institute

    Denver, Colorado · Active not recruiting

  • Presbyterian - Saint Lukes Medical Center - Health One

    Denver, Colorado · Active not recruiting

  • Rocky Mountain Cancer Centers-Midtown

    Denver, Colorado · Active not recruiting

  • Rocky Mountain Cancer Centers-Rose

    Denver, Colorado · Active not recruiting

  • Rocky Mountain Cancer Centers - Swedish

    Englewood, Colorado · Active not recruiting

  • The Melanoma and Skin Cancer Institute

    Englewood, Colorado · Active not recruiting

  • Rocky Mountain Cancer Centers-Lakewood

    Lakewood, Colorado · Active not recruiting

  • Rocky Mountain Cancer Centers-Littleton

    Littleton, Colorado · Active not recruiting

  • Rocky Mountain Cancer Centers-Sky Ridge

    Lone Tree, Colorado · Active not recruiting

  • Rocky Mountain Cancer Centers-Longmont

    Longmont, Colorado · Active not recruiting

  • Rocky Mountain Cancer Centers-Thornton

    Thornton, Colorado · Active not recruiting

  • Beebe Medical Center

    Lewes, Delaware · Recruiting

  • Beebe South Coastal Health Campus

    Millville, Delaware · Recruiting

  • Helen F Graham Cancer Center

    Newark, Delaware · Recruiting

  • Medical Oncology Hematology Consultants PA

    Newark, Delaware · Recruiting

Showing 40 of 165 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.